FindTrial
Sign In

Effect of long term small doses of EPA/DHA supplement on cardiovascular risk factors among people with metabolic syndrome

Effect of long term small doses of EPA/DHA supplement on cardiovascular risk factors among people with metabolic syndrome: A Placebo controlled, Random, double-blind and parallel study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006329
Enrollment
Unknown
Registered
2014-09-30
Start date
2015-05-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome

Interventions

test group:300mgEPA/DHA per day
control group:corn/soybean oil

Sponsors

Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: To be aged between 40-65 years; Subjects with MetS and no evidence of cardiovascular disease, acute inflammatory or chronic disease.

Exclusion criteria

Exclusion criteria: Individuals taking regular cardiovascular; Medications, statins, antioxidant vitamin supplementation, antiinflammatory or steroid substances during the past 2 months.

Design outcomes

Primary

MeasureTime frame
blood lipids;blood NO;blood inflammantory cytokine;—

Contacts

Public ContactZhou Quan
joan_zq@126.com+86 13929538406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026